Powder: -20°C for 3 years | In solvent: -80°C for 1 year
FGTI-2734 mesylate, a RAS C-terminal mimetic compound with dual farnesyl transferase (FT) and geranylgeranyl transferase-1 (GGT) inhibitory activities (IC50s of 250 nM and 520 nM for FT and GGT, respectively), mitigates KRAS resistance by preventing its membrane localization, effectively impeding mutant KRAS patient-derived pancreatic tumors.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 311.00 | |
10 mg | Inquiry | $ 575.00 | |
50 mg | Inquiry | $ 1,762.00 | |
100 mg | Inquiry | $ 3,081.00 | |
200 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry | |
1 mL * 10 mM (in DMSO) | Inquiry | $ 414.00 |
Description | FGTI-2734 mesylate, a RAS C-terminal mimetic compound with dual farnesyl transferase (FT) and geranylgeranyl transferase-1 (GGT) inhibitory activities (IC50s of 250 nM and 520 nM for FT and GGT, respectively), mitigates KRAS resistance by preventing its membrane localization, effectively impeding mutant KRAS patient-derived pancreatic tumors. |
Targets&IC50 | GGT:520 nM , FT:250 nM |
In vitro | FGTI-2734 mesylate (3-30 μM;?72 hours) inhibits both protein prenylation of HDJ2, RAP1A, KRAS and NRAS. FGTI-2734 mesylate (1-30 μM; 72 hours) induces apoptosis in mutant KRAS-dependent, but not mutant KRAS- independent, human cancer cells. ??FGTI-2734 inhibits KRAS membrane localization in RAS-transformed murine NIH3T3 cells and in mutant KRAS human cancer cells. |
In vivo | FGTI-2734 mesylate (intraperitoneally;?100 mg/kg/day for 18 to 25 days) only inhibits tumor growth in mutant KRAS-dependent tumors but not in mutant KRAS-independent tumors. |
Synonyms | FGTI-2734 mesylate |
Molecular Weight | 606.73 |
Formula | C27H35FN6O5S2 |
CAS No. | 2702297-24-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 75 mg/mL (123.61 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
FGTI-2734 mesylate (1247018-19-4 free base) 2702297-24-1 Others FGTI-2734 Mesylate FGTI2734 Mesylate FGTI-2734 mesylate FGTI2734 mesylate (1247018194 free base) 1247018-19-4 1247018-19-4 free base FGTI 2734 mesylate (1247018 19 4 free base) FGTI 2734 Mesylate inhibitor inhibit